Skip to content

VALN

Valneva SE

NASDAQ · Healthcare · Biotechnology · FR

$5.63
+2.18%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
9.00x
P/E 2028E
16.85x
P/S forward
2.73x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
5.88x
Price / sales
3.32x
Price / cash flow
-5.74x

Enterprise value

Enterprise value
$633.1M
EV / sales
3.94x
EV / EBITDA
-6.07x
EV / EBIT
-4.87x
Market cap
$533.9M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026